039840 — Dio Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual income statement for Dio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	150,037	131,306	155,818	119,650	164,078
Cost of Revenue
Gross Profit	107,819	89,549	113,108	73,796	110,226
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	116,219	141,134	136,045	169,632	154,178
Operating Profit	33,819	-9,827	19,773	-49,982	9,900
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	33,811	-21,076	10,405	-50,458	-6,595
Provision for Income Taxes
Net Income After Taxes	28,121	-20,108	2,619	-41,320	-1,363
Minority Interest
Net Income Before Extraordinary Items
Net Income	28,255	-20,458	3,311	-41,320	-1,363
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	28,255	-20,458	3,311	-41,320	-1,363
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1,986	-1,126	300	-2,355	-68.5
Dividends per Share